Outset Medical Inc (OM)
2.25
+0.09
(+4.17%)
USD |
NASDAQ |
Apr 18, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Cash from Operations (TTM): -131.37M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -131.37M |
| September 30, 2023 | -141.44M |
| June 30, 2023 | -141.75M |
| March 31, 2023 | -152.15M |
| December 31, 2022 | -145.73M |
| September 30, 2022 | -143.90M |
| June 30, 2022 | -137.72M |
| Date | Value |
|---|---|
| March 31, 2022 | -129.98M |
| December 31, 2021 | -130.26M |
| September 30, 2021 | -123.43M |
| June 30, 2021 | -124.41M |
| March 31, 2021 | -112.74M |
| December 31, 2020 | -99.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-152.15M
Minimum
Mar 2023
-99.02M
Maximum
Dec 2020
-131.84M
Average
-131.37M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
| AngioDynamics Inc | -17.20M |
| Baxter International Inc | 1.726B |
| Allurion Technologies Inc | -63.98M |
| Perspective Therapeutics Inc | -36.91M |
| Xtant Medical Holdings Inc | -9.515M |